191671-47-3

Basic information

• Product Name: 1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-(6-aMino-6-oxohexyl)hexahydro-2-oxo-, (3aS,4S,6aR)-
• Synonyms: 1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-(6-aMino-6-oxohexyl)hexahydro-2-oxo-, (3aS,4S,6aR)-
• CAS NO: 191671-47-3
• Molecular Formula: C16H28N4O3S
• Molecular Weight: 356.48352
• Mol File: 191671-47-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 761.6±55.0 °C(Predicted)
• Appearance: /
• Density: 1.173±0.06 g/cm3(Predicted)
• PKA: 13.90±0.40(Predicted)
• CAS DataBase Reference: 1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-(6-aMino-6-oxohexyl)hexahydro-2-oxo-, (3aS,4S,6aR)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-(6-aMino-6-oxohexyl)hexahydro-2-oxo-, (3aS,4S,6aR)-(191671-47-3)
• EPA Substance Registry System: 1H-Thieno[3,4-d]iMidazole-4-pentanaMide, N-(6-aMino-6-oxohexyl)hexahydro-2-oxo-, (3aS,4S,6aR)-(191671-47-3)

Safety Data

• Hazardous Substances Data: 191671-47-3(Hazardous Substances Data)

Upstream product

• 35013-72-0 biotin N-Hydroxysuccinimide ester 
• 60-32-2 6-aminohexanoic acid 
• 58-85-5 biotin 

Relevant articles and documents

BIOCONJUGATES OF HETEROCYCLIC COMPOUNDS

The invention provides bioconjugates of heterocylic compounds such as S-adenosylmethionine and S-adenosylhomocysteine with biotin or digoxigenin. The bioconjugates also include carbon and nitrogen linker moiteies of varying length that are used to attach such compounds to biotin or digoxigenin. The conjugates are useful in immunoassays. The invention provides a method for detecting SAM and SAH, comprising the steps of: (a) preparing the following components: (i) bio-conjugates of SAM, SAM analogs or SAH; (ii) an europium, a terbium cryptate or other fluorophore as a donor that has a specific ligand for the tracer in the bio-conjugates of (i); (iii) an acceptor fluorescent dye that has the excitation spectra overlap those of donor's emissions and has an antibody specific for SAM or SAH labeled; (b) addition of the biological fluid containing said SAM or SAH; and (c) spectroscopic measurement of the fluorescence of the donor and the fluorescence of from the acceptor.